ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DRTS Alpha Tau Medical Ltd

2.50
0.06 (2.46%)
After Hours
Last Updated: 06:06:32
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Alpha Tau Medical Ltd DRTS NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.06 2.46% 2.50 06:06:32
Open Price Low Price High Price Close Price Previous Close
2.41 2.41 2.52 2.50 2.44
more quote information »

Recent News

Date Time Source Heading
25/3/202423:50GLOBEAlpha Tau to Present at the Jefferies Radiopharma Innovation..
08/3/202408:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/3/202408:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/3/202408:01GLOBEAlpha Tau Medical Announces Full Year 2023 Financial Results..
27/2/202400:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202400:30GLOBEAlpha Tau to Participate in Barclays 26th Annual Global..
21/12/202301:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202301:15GLOBEAlpha Tau to Present at the 42nd Annual J.P. Morgan..
19/12/202303:09EDGAR2Form 144 - Report of proposed sale of securities
30/11/202300:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/11/202300:30GLOBEAlpha Tau to Participate in Sidoti Small-Cap Conference
29/11/202300:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202300:30GLOBEAlpha Tau Announces Highly Promising Interim Results from..
21/11/202322:18EDGAR2Form 144 - Report of proposed sale of securities
21/11/202300:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/11/202300:30GLOBEAlpha Tau Submits to Japanese PMDA for Pre-Market Approval..
17/11/202308:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/11/202308:30GLOBEAlpha Tau Medical Announces Third Quarter 2023 Financial..
02/11/202308:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/11/202323:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202323:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/10/202323:30GLOBEAlpha Tau Enters Into Long-Term Lease of Site in New..
25/10/202300:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/10/202300:00GLOBEFormer U.S. Commissioner of Food and Drug Administration..
27/9/202321:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/9/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
14/9/202322:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/9/202322:30GLOBEAlpha Tau Treats First Patient with Advanced Inoperable..
12/9/202306:16EDGAR2Form F-3 - Registration statement by foreign private issuers
29/8/202306:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202306:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/8/202306:02GLOBEAlpha Tau Medical Announces Second Quarter 2023 Financial..
24/8/202322:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202307:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/8/202307:00GLOBEAlpha Tau Announces Robust Long-Term Safety and Efficacy..
02/8/202323:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
25/5/202306:01GLOBEAlpha Tau Medical to Participate in June Investor..
24/5/202306:01GLOBEAlpha Tau Medical Announces First Quarter 2023 Financial..
18/5/202306:30GLOBEAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer..
12/5/202306:00GLOBEAlpha Tau Announces the Publication of its US Multicenter..
04/5/202306:00GLOBEAlpha Tau Medical to Present at Guggenheim..

Your Recent History

Delayed Upgrade Clock